Hunan Er-Kang Pharmaceutical Co., Ltd (SHE:300267)
China flag China · Delayed Price · Currency is CNY
4.410
-0.010 (-0.23%)
May 20, 2026, 12:44 PM CST

SHE:300267 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
9,1177,0335,7346,6217,3229,777
Market Cap Growth
86.50%22.66%-13.40%-9.58%-25.11%12.59%
Enterprise Value
8,7046,6975,3446,2567,2519,643
Last Close Price
4.423.412.783.213.524.70
PE Ratio
----159.37-
Forward PE
-38.5438.5438.5438.5438.54
PS Ratio
8.606.035.033.713.924.37
PB Ratio
2.301.771.301.381.452.01
P/TBV Ratio
2.461.891.411.491.582.22
P/FCF Ratio
110.1475.06--68.10-
P/OCF Ratio
36.1927.3034.4044.6126.06105.49
EV/Sales Ratio
8.215.754.693.513.884.31
EV/EBITDA Ratio
71.2248.0552.75386.2945.89234.66
EV/FCF Ratio
105.1571.47--67.43-
Debt / Equity Ratio
0.180.150.120.070.080.05
Debt / EBITDA Ratio
5.874.034.7516.272.435.41
Debt / FCF Ratio
8.666.28--3.75-
Net Debt / Equity Ratio
-0.09-0.10-0.07-0.08-0.09-0.10
Net Debt / EBITDA Ratio
-3.02-2.86-3.05-24.65-3.01-12.40
Net Debt / FCF Ratio
-4.23-4.2610.704.45-4.421.99
Asset Turnover
0.210.230.210.320.330.37
Inventory Turnover
1.371.631.321.991.902.61
Quick Ratio
1.391.491.451.561.532.10
Current Ratio
2.092.232.432.872.883.90
Return on Equity (ROE)
-9.88%-9.53%-8.52%-4.50%0.75%-14.90%
Return on Assets (ROA)
-0.67%-0.43%-1.06%-2.02%-0.12%-1.56%
Return on Invested Capital (ROIC)
-1.51%-0.91%-2.12%-4.07%-0.24%-3.21%
Return on Capital Employed (ROCE)
-1.30%-0.90%-2.00%-3.80%-0.20%-3.10%
Earnings Yield
-4.33%-5.40%-6.51%-2.95%0.63%-8.09%
FCF Yield
0.91%1.33%-0.50%-1.36%1.47%-2.63%
Dividend Yield
----0.85%-
Payout Ratio
----10.29%-
Buyback Yield / Dilution
0.15%-0.01%-0.01%-0.11%0.11%0.04%
Total Shareholder Return
0.15%-0.01%-0.01%-0.11%0.96%0.04%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.